The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis
Keywords: AS101; trichloro(dioxoethylene-O,Oâ²) tellurate; EAE; experimental autoimmune encephalomyelitis; MOG; myelin oligodendrocyte glycoprotein; Inflammation; GM-CSF; IL-17; Signal transduction; Th17 cells; Stat3;